Virtual Reality–Assisted Trauma-Focused CBT for PTSD
Official title: Exploring the Feasibility of Virtual Reality-Assisted Trauma-Focused Cognitive Behavioural Therapy for PTSD: A Mixed Methods Study
Run by Queen's University, Belfast · NCT07914634 · Data updated 2026-11-12
A VR-assisted trauma-focused CBT approach is being tested to see if it helps adults with PTSD related to Northern Ireland–specific trauma.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Queen's University, Belfast Academic / other |
| Locations | 1 site (Newtownabbey, County Antrim) |
| Status | Recruiting |
| Started | October 5, 2026 |
| Main results expected | October 31, 2028 |
| Study ends | October 31, 2028 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07914634 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older with PTSD symptoms (PCL-5 score >31) related to NI-related trauma who are willing to engage in TF-CBT.
✕Probably not a fit
Individuals with active suicidality, certain psychiatric histories, or those not suitable for TF-CBT may not benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study uses immersive virtual reality (VR) photoscan environments combined with trauma-focused CBT to treat PTSD symptoms in adults. The trial targets individuals with type 1 trauma experiences associated with Northern Ireland's conflict and assesses safety and feasibility in a controlled setting. Participants engage in TF-CBT delivered within a VR framework, with real-time monitoring of responses to tailor the exposure and therapy. Exclusion criteria include seizure history, certain mental illnesses, recent active suicidality, and recent TF-CBT participation. The study is led by Queen’s University Belfast at Whiteabbey Hospital’s Psychological Therapies Service.
Why it matters
Potential benefit: If successful, the approach could offer a more immersive and personalized way to reduce PTSD symptoms and improve engagement with therapy.
How similar studies have gone: VR-assisted therapy for PTSD has shown potential in early studies, but large-scale evidence remains limited for this specific Northern Ireland–focused TF-CBT integration.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults who self-report the experience of type 1 trauma (NI related) * PTSD symptoms as identified via PCL-5 \> 31 * Ability to give informed consent -Suitable and willingness to engage in TF- CBT Exclusion Criteria: * History of seizures, seizure disorder, or epilepsy * History of bipolar disorder, psychosis, or schizophrenia * Younger than 18 years old * Previously engaged in TF-CBT within the PTS in past 12 months * Actively suicidal or undertaken suicidal action in past 3 months\* * Severe substance dependency \*Participants who have been actively suicidal or have undertaken suicidal actions within the past three months will be excluded from the study. However, given the complexities of mental health and its treatment, the presence of passive suicidal ideation (e.g., thoughts of not wanting to live, without intent or plan) does not automatically lead to exclusion, provided that the participant is assessed as not being at immediate risk. Clinical judgement will be used during the screening process, and ongoing risk will be monitored throughout the study. A distress protocol is in place for the intervention
Where it's running
-
Whiteabbey Hospital - Psychological Therapies Service
Newtownabbey, County Antrim, United Kingdom Recruiting
Study contacts
- Study coordinator: Paul Best, PhD, MsC
- Email: p.best@qub.ac.uk
- Phone: 02890973256
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
COMP360 psilocybin for PTSD: see if it helps reduce symptoms with guided support
This study tests COMP360 (a lab-made psilocybin) to see if it can help reduce PTSD symptoms in adults, with supervision from a trained team.
-
ReVIVE for mTBI: Using VR and therapy to help adults with mild traumatic brain injury
This study tests a virtual reality therapy combined with standard psychotherapy to see if it can reduce PTSD symptoms and improve executive function in adults with mild traumatic brain injury.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Predicting nightmare awakenings in PTSD using an AI algorithm
The study tests an AI tool called CAUD-PIN to see if it can reliably predict when trauma-related nightmares will wake military personnel or veterans with PTSD.
-
Dexmedetomidine with taVNS to see if PTSD after trauma surgery can be reduced
This study tests whether giving dexmedetomidine together with transcutaneous vagus nerve stimulation after emergency trauma surgery can lower the chances of developing PTSD.
-
Early Intervention After Sepsis-ICU to Reduce PTSD
This study tests whether an early psychiatric interview after discharge from the ICU for sepsis can help reduce PTSD and related symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.